231 related articles for article (PubMed ID: 31139686)
1. Corpus callosum axon diameter relates to cognitive impairment in multiple sclerosis.
Huang SY; Fan Q; Machado N; Eloyan A; Bireley JD; Russo AW; Tobyne SM; Patel KR; Brewer K; Rapaport SF; Nummenmaa A; Witzel T; Sherman JC; Wald LL; Klawiter EC
Ann Clin Transl Neurol; 2019 May; 6(5):882-892. PubMed ID: 31139686
[TBL] [Abstract][Full Text] [Related]
2. Age-related alterations in axonal microstructure in the corpus callosum measured by high-gradient diffusion MRI.
Fan Q; Tian Q; Ohringer NA; Nummenmaa A; Witzel T; Tobyne SM; Klawiter EC; Mekkaoui C; Rosen BR; Wald LL; Salat DH; Huang SY
Neuroimage; 2019 May; 191():325-336. PubMed ID: 30790671
[TBL] [Abstract][Full Text] [Related]
3. 'Importance sampling' in MS: use of diffusion tensor tractography to quantify pathology related to specific impairment.
Lin X; Tench CR; Morgan PS; Niepel G; Constantinescu CS
J Neurol Sci; 2005 Oct; 237(1-2):13-9. PubMed ID: 16109428
[TBL] [Abstract][Full Text] [Related]
4. Segmented corpus callosum diffusivity correlates with the Expanded Disability Status Scale score in the early stages of relapsing-remitting multiple sclerosis.
Rimkus Cde M; Junqueira Tde F; Callegaro D; Otaduy MC; Leite Cda C
Clinics (Sao Paulo); 2013; 68(8):1115-20. PubMed ID: 24037007
[TBL] [Abstract][Full Text] [Related]
5. Multimodal assessment of normal-appearing corpus callosum is a useful marker of disability in relapsing-remitting multiple sclerosis: an MRI cluster analysis study.
Barone S; Caligiuri ME; Valentino P; Cherubini A; Chiriaco C; Granata A; Filippelli E; Tallarico T; Nisticò R; Quattrone A
J Neurol; 2018 Oct; 265(10):2243-2250. PubMed ID: 30051273
[TBL] [Abstract][Full Text] [Related]
6. The impact of gradient strength on in vivo diffusion MRI estimates of axon diameter.
Huang SY; Nummenmaa A; Witzel T; Duval T; Cohen-Adad J; Wald LL; McNab JA
Neuroimage; 2015 Feb; 106():464-72. PubMed ID: 25498429
[TBL] [Abstract][Full Text] [Related]
7. Influence of corpus callosum damage on cognition and physical disability in multiple sclerosis: a multimodal study.
Llufriu S; Blanco Y; Martinez-Heras E; Casanova-Molla J; Gabilondo I; Sepulveda M; Falcon C; Berenguer J; Bargallo N; Villoslada P; Graus F; Valls-Sole J; Saiz A
PLoS One; 2012; 7(5):e37167. PubMed ID: 22606347
[TBL] [Abstract][Full Text] [Related]
8. Use of combined conventional and quantitative MRI to quantify pathology related to cognitive impairment in multiple sclerosis.
Lin X; Tench CR; Morgan PS; Constantinescu CS
J Neurol Neurosurg Psychiatry; 2008 Apr; 79(4):437-41. PubMed ID: 17673493
[TBL] [Abstract][Full Text] [Related]
9. Corpus callosum index correlates with brain volumetry and disability in multiple sclerosis patients.
Sugijono SE; Mulyadi R; Firdausia S; Prihartono J; Estiasari R
Neurosciences (Riyadh); 2020 Jul; 25(3):193-199. PubMed ID: 32683399
[TBL] [Abstract][Full Text] [Related]
10. Associations between corpus callosum damage, clinical disability, and surface-based homologous inter-hemispheric connectivity in multiple sclerosis.
Russo AW; Stockel KE; Tobyne SM; Ngamsombat C; Brewer K; Nummenmaa A; Huang SY; Klawiter EC
Brain Struct Funct; 2022 Dec; 227(9):2909-2922. PubMed ID: 35536387
[TBL] [Abstract][Full Text] [Related]
11. MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index.
Granberg T; Bergendal G; Shams S; Aspelin P; Kristoffersen-Wiberg M; Fredrikson S; Martola J
J Neuroimaging; 2015; 25(6):996-1001. PubMed ID: 25786805
[TBL] [Abstract][Full Text] [Related]
12. Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis.
Cader S; Johansen-Berg H; Wylezinska M; Palace J; Behrens TE; Smith S; Matthews PM
Neuroimage; 2007 May; 36(1):19-27. PubMed ID: 17398118
[TBL] [Abstract][Full Text] [Related]
13. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
14. Corpus callosum atrophy as a marker of clinically meaningful cognitive decline in secondary progressive multiple sclerosis. Impact on employment status.
Papathanasiou A; Messinis L; Zampakis P; Papathanasopoulos P
J Clin Neurosci; 2017 Sep; 43():170-175. PubMed ID: 28601572
[TBL] [Abstract][Full Text] [Related]
15. Imaging G-Ratio in Multiple Sclerosis Using High-Gradient Diffusion MRI and Macromolecular Tissue Volume.
Yu F; Fan Q; Tian Q; Ngamsombat C; Machado N; Bireley JD; Russo AW; Nummenmaa A; Witzel T; Wald LL; Klawiter EC; Huang SY
AJNR Am J Neuroradiol; 2019 Nov; 40(11):1871-1877. PubMed ID: 31694819
[TBL] [Abstract][Full Text] [Related]
16. The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis.
Caligiuri ME; Barone S; Cherubini A; Augimeri A; Chiriaco C; Trotta M; Granata A; Filippelli E; Perrotta P; Valentino P; Quattrone A
Neuroimage Clin; 2015; 7():28-33. PubMed ID: 25610764
[TBL] [Abstract][Full Text] [Related]
17. Diffusion tensor fractional anisotropy of the normal-appearing seven segments of the corpus callosum in healthy adults and relapsing-remitting multiple sclerosis patients.
Hasan KM; Gupta RK; Santos RM; Wolinsky JS; Narayana PA
J Magn Reson Imaging; 2005 Jun; 21(6):735-43. PubMed ID: 15906348
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Axonal Disease in Patients with Multiple Sclerosis Using High-Gradient-Diffusion MR Imaging.
Huang SY; Tobyne SM; Nummenmaa A; Witzel T; Wald LL; McNab JA; Klawiter EC
Radiology; 2016 Jul; 280(1):244-51. PubMed ID: 26859256
[TBL] [Abstract][Full Text] [Related]
19. MRI of the corpus callosum in multiple sclerosis: association with disability.
Ozturk A; Smith SA; Gordon-Lipkin EM; Harrison DM; Shiee N; Pham DL; Caffo BS; Calabresi PA; Reich DS
Mult Scler; 2010 Feb; 16(2):166-77. PubMed ID: 20142309
[TBL] [Abstract][Full Text] [Related]
20. Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: Results of a 17-year longitudinal study.
Granberg T; Martola J; Bergendal G; Shams S; Damangir S; Aspelin P; Fredrikson S; Kristoffersen-Wiberg M
Mult Scler; 2015 Aug; 21(9):1151-8. PubMed ID: 25480866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
